Lawyer profile
Kevin Sforza
Sidley
- Firm
- Sidley
- Practice
- Food, Drug and Medical Device
- Office
- Not stated
- Active in the record
- 2023 to 2026
Deal experience
Deals
7 announced deals in the record Sidley Represents Goldman Sachs Alternatives in Acquisition of Tosca From Apax Funds 12 Aug 2026
Sidley Represents Special Committee of the Board of Directors of Utz Brands in Its US$2.9 Billion Take-Private Transaction 22 Jul 2026
Sidley Represents Immunovant in US$550 Million Offering 16 Dec 2025
Sidley Represents Nuvalent in Pricing of US$500 Million Public Offering 21 Nov 2025
Sidley Represents Radiology Partners and Its Subsidiary Mosaic Clinical Technologies in the Acquisition of Cognita Imaging 20 Nov 2025
Sidley Represents Tata Consumer Products in Its Acquisition of Organic India 22 Jan 2024
Sidley Represents TowerBrook in Its Investment in Demakes Enterprises 14 Dec 2023
Deal alerts PRO
Get an email when Kevin Sforza is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile